Celebrating Women Trailblazers at #HERStory2024 Gala! We were honored to be a silver sponsor at the #HERStory2024 Gala in Bethesda, Maryland! This incredible event shines a spotlight on remarkable women trailblazers in the life sciences who have left an indelible mark in our region. Their groundbreaking work inspires us all! It was a beautiful evening and we were excited to celebrate alongside the phenomenal women at Women In Bio - Capital Region and ATCC as well as the impactful women in the life sciences throughout the capital region. Special thanks to the ladies of MaxCyte for a lovely evening. Akanksha Goswami, Akilah Hill, Tresia O'Shea and Sheila Smaw. #HERStory2024 #MaxCyte #CellandGeneTherapy #WomeninBio
MaxCyte, Inc.
Biotechnology
Rockville, Maryland 7,952 followers
Let's Build Better Cells Together
About us
At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients’ lives. We have spent more than 20 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today’s processes to innovate tomorrow’s solutions. Our ExPERT™ platform, which is based on our Flow Electroporation technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: three instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health. Our Vision: Together, we maximize the potential of cells to improve lives. Our Mission: We build trust with our customers, and together we leverage best-in-class technology and expertise to solve the toughest challenges in cell engineering, bringing therapies to patients. Our Core Values: - We value and respect each other, our partners, and patients - We remain undaunted in our commitment to relieving the burden of disease - We dig deep, working together to understand the problem, and always find a way - We stay curious and connected, and never get complacent - We approach each person, each situation with compassion and transparency - We take pride in the excellence of our technology and the expertise we deliver
- Website
-
http://www.maxcyte.com
External link for MaxCyte, Inc.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Rockville, Maryland
- Type
- Public Company
- Founded
- 1999
- Specialties
- Vaccine Development, Protein Production, Transfection, Cell Therapy, Gene Therapy, Cancer, Immunotherapy, Electroporation, MyExpertPlatform, Tcell, NKcell, Bispecifics, Gene Editing, Cancer Research, Immuno-oncology, Stem Cell, CARMA, Cell Engineering, Biotechnology, Life Sciences, and Innovation
Locations
-
Primary
9713 Key West Ave
Suite 400
Rockville, Maryland 20850, US
Employees at MaxCyte, Inc.
Updates
-
Join us at booth #1228 for our daily demos at 3:30 p.m. and 6:00 p.m. at #ASGCT2024! Stop by and learn how MaxCyte's electroporation technology can assist with your cell therapy development. Also enter to win: “BYOB Wine Lovers”: This package includes a wine travel bag, a corkscrew, a lighted magnifying glass, and a $500 gift card to Wine of the Month. Perfect for wine enthusiasts. We look forward to connecting with you. #ASGCT2024 #MaxCyte #geneandcelltherapy #genetherapy #celltherapy
-
Tomorrow at #ASGCT2024! Join Ashley Strickland-Dietz, Ph.D., MaxCyte Immunology Scientist I, for two exciting presentations: Poster Presentation: Discover non-viral engineering of primary human macrophages using MaxCyte's cGMP-compliant electroporation platform. Find Dr. Strickland at poster #288. Oral Presentation: Today at 5:15p.m. in Ballroom 2, learn about the MaxCyte ExPERT GTx™ electroporation instrument and its application in engineering macrophages for cell therapy. See you there! #GeneTherapy #CellTherapy 🧬🔬
-
Tomorrow at 12:00 p.m. join Peter Gee, PhD, MaxCyte Senior Field Applications Scientist as he presents a poster at #ASGCT2024 discussing efficient scalable manufacturing of virus-like particles for the delivery of CRISPR-Cas9 ribonucleoproteins using a cGMP-compliant electroporation platform. Dr. Gee looks forward to seeing you there! #cellandgenetherapy #celltherapy #genetherapy
-
While you are making your way around #ASGCT2024 be sure to drop by our booth #1228 to learn about MaxCyte’s cGMP-compliant non-viral cell engineering platform. Attend live demo's daily at 3:30 p.m. and 6:00 p.m. to meet our Field Applications Scientists who assist researchers to optimize their cell & gene therapy workflows. Tonight, be sure to attend our networking event at Blackwall Hitch from 7:00 p.m. - 9:30 p.m. If you haven't registered there is still time, register now. Thanks Ali Soleymannezhad for being a wonderful host! https://bit.ly/3QpkeDd
-
Please join us for a unique panel discussion at ASGCT: Overcoming Challenges in Translating Research to Scalable Manufacturing 📅 Date: May 9th, 2024 ⏰ Time: 8:30 am (EST) 📍 Location: Room 309-310 We’ll be diving into the complexities of translating research development into scalable clinical manufacturing processes with experts at key stakeholders in the process: from cell therapy developer, technology enabler and CDMO. Speakers: • Maher Masoud, President and Chief Executive Officer, MaxCyte • Jason Bock, Chief Executive Officer, CTMC / A joint venture between Resilience + MD Anderson Cancer Center • Thomas Leitch, Chief Technology Officer, KSQ Therapeutics, Inc. • Benjamin Askin, Scientist, Cellular Process Development, KSQ Therapeutics, Inc. Learn from these leaders as they share insights, strategies, and success stories. 🔗 Learn more: https://bit.ly/3JIj95J #ASGCT2024 #CellTherapy #GeneTherapy #BiotechConference
-
Today, at 12:00 p.m. MaxCyte’s Lauren Unsworth will present a poster on non-viral cell engineering of peripheral blood natural killer cells using a GMP-compliant, scalable electroporation platform. Join Lauren at poster #861 and learn about the stellar research being conducted using MaxCyte’s instruments. #ASGCT2024
-
It’s a beautiful day in Baltimore, Maryland and ASGCT is off to a great start! Join us at our MaxCyte booth #1228 at #ASGCT2024 to learn about how MaxCyte's scientific expertise and unapparelled support can help lead you from concept to commercialization and beyond. Be sure to join our live demo sessions daily at 3:30 p.m. and 6:00 p.m. in our booth to learn about MaxCyte’s electroporation technology and get hands on experience with our GTx instrument. Also enter to win: “BYOB Wine Lovers”: This package includes a wine travel bag, a corkscrew, a lighted magnifying glass, and a $500 gift card to Wine of the Month. Perfect for wine enthusiasts. “Outdoor Enthusiasts”: This package inlcudes a hydration backpack, voice-activated walkie talkies, a sturdy water bottle, and a hiking journal. Now you are ready for your next adventure. “Weekend Warrior”: This package includes a gym bag, a Theragun for muscle relief, bodyweight exercise cards, and relaxing bath bombs. Ideal for active weekends. #ASGCT2024 #MaxCyte #geneandcellTherapy #genetherapy #celltherapy
-
Attending #ASGCT2024? Be sure to visit our poster and oral presentations! Poster 861 Wednesday, May 8, 2024, in the Exhibit Hall from 12:00 to 7:00 p.m. ET Lauren Unsworth, Research Associate II at MaxCyte will present a poster on non-viral cell engineering of peripheral blood natural killer cells using a GMP-compliant, scalable electroporation platform. Poster 1733 Friday, May 10, 2024, in the Exhibit Hall from 12:00 to 7:00 p.m. ET Peter Gee, Ph.D., Senior Field Application Scientist at MaxCyte will present a poster on efficient scalable manufacturing of virus-like particles for the delivery of CRISPR-Cas9 ribonucleoproteins using a cGMP-compliant electroporation platform. Oral presentation Friday, May 10, 2024, in Ballroom 2 from 5:15 to 5:30 p.m. ET Ashley Strickland-Dietz, Ph.D., Immunology Scientist I at MaxCyte will present on non-viral engineering of primary human macrophages using a cGMP-compliant electroporation platform. We look forward to speaking with you! #ASGCT24 #Cas9 #CRISPR
-
We're ready for #ASGCT24! Head on over to booth #1228, May 7-11 to learn more about MaxCyte’s cGMP-compliant non-viral cell engineering platform and connect with our awesome Field Application Scientist, Leif Anderson, PhD, Megan Embrey, PhD, Nitin Kulkarni, PhD and Tiffany King Peoples, PhD. We're here and we're ready to connect with you!